2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Buy Kotak Mahindra Bank Ltd For Target Rs.2,350 by P...
Hold Titan Company Ltd For Target Rs.3,830 by Prabhu...
Buy Cipla Ltd For Target Rs.1,730 by Prabhudas Lilad...
Hold Grindwell Norton Ltd For Target Rs.1,739 by Pra...
Nifty & Bank Nifty Weekly Outlook 02st Aug 2025 by C...
Embracing Tranquility: A Glimpse into the Lifestyle ...
Title: Timeless Tokens of Love: The Rise of Fashion ...
Study finds inflammatory pathways behind asthma atta...
I hope Yashasvi converts his 50 into century on Day ...
CM Stalin launches statewide health screening camps,...
